Drug Trial Radar · NCT00878709
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,840
Actual
Start
Jul 9, 2009
Primary completion
Aug 21, 2014
Study completion Oct 4, 2019
Sponsor
- Lead sponsor
- Puma Biotechnology, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 9, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate whether neratinib can further reduce the risk of recurrence from previously diagnosed HER-2 positive breast cancer after adjuvant treatment with trastuzumab.
Conditions
- Breast Cancer
Interventions
neratinibDrug
placeboOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Invasive Disease-free Survival (iDFS) in Neratinib Arm Compared to Placebo Arm at Year 2Time frame: From randomization until time of event up to 2 years
- Kaplan-Meier Estimates of Invasive Disease-free Survival (iDFS) at Year 2 by Treatment ArmsTime frame: From randomization until time of event up to 2 years
Locations
494 sites in 40 countries. Site status is shown where the registry gives one.
Anniston Oncology
Anniston, Alabama
Birmingham Hematology and Oncology Associates, LLC
Birmingham, Alabama
Arizona Oncology Associates, PC - HAL
Phoenix, Arizona
Arizona Oncology Associates, PC - NAHOA
Sedona, Arizona
Arizona Oncology Associates
Tucson, Arizona
Arizona Cancer Center
Tucson, Arizona
Northeast Arkansas Clinic
Jonesboro, Arkansas
Cedars-Sinai Medical Group
Beverly Hills, California
Ronald Yanagihara, M.D.
Gilroy, California
Glendale Adventist Medical Center Cancer Services
Glendale, California
California Cancer Care
Greenbrae, California
Beaver Medical Group, L.P.
Highland, California
Breastlink Medical Group
Long Beach, California
Long Beach Memorial Medical Center
Long Beach, California
Facey Medical Group
Mission Hills, California
Gynecologic Oncology Associates
Newport Beach, California
Ventura County Hematology-Oncology Specialists
Oxnard, California
Desert Hematology Oncology Medical Group, Inc
Rancho Mirage, California
Helen Diller Family University of California San Francisco Comprehensive Cancer Center
San Francisco, California
San Francisco Oncology Associates
San Francisco, California
Redwood Regional Medical Group
Santa Rosa, California
The Cancer Prevention and Treatment Center
Soquel, California
Cancer Center of Central Connecticut
Southington, Connecticut
Hematology Oncology, PC
Stamford, Connecticut
Connecticut Oncology and Hematology
Torrington, Connecticut
Washington Cancer Institute at Washington Hospital Center
Washington D.C., District of Columbia
Innovative Medical Research of South Florida, Inc.
Aventura, Florida
University Cancer Institute, LLC
Boynton Beach, Florida
North Broward Medical Center
Deerfield Beach, Florida
Broward General Medical Center
Fort Lauderdale, Florida
Florida Cancer Specialists and Research Institute
Gainesville, Florida
Lakeland Regional Cancer Center
Lakeland, Florida
Hematology Oncology Associates
Loxahatchee Groves, Florida
Florida Cancer Affiliates - Ocala
Ocala, Florida
Mid-Florida Hematology & Oncology Centers, PA
Orange City, Florida
Cancer Centers of Florida
Orlando, Florida
M.D. Anderson Cancer Center Orlando
Orlando, Florida
Florida Cancer Research Institute
Plantation, Florida
Hematology Oncology Associates of Treasure Coast
Port Saint Lucie, Florida
Florida Cancer Specialists, P.L.
St. Petersburg, Florida
Showing 40 of 494 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.